Submitted by Anonymous (not verified) on 21 January 2026 - 15:34
Human medicines European public assessment report (EPAR): Lyumjev (previously Liumjev), insulin lispro, Date of authorisation: 24/03/2020, Revision: 8, Status: Authorised
Source: